nodes	percent_of_prediction	percent_of_DWPC	metapath
Clindamycin—CYP3A4—Ifosfamide—testicular cancer	0.109	0.428	CbGbCtD
Clindamycin—CYP3A4—Vinblastine—testicular cancer	0.058	0.227	CbGbCtD
Clindamycin—CYP3A4—Etoposide—testicular cancer	0.0523	0.205	CbGbCtD
Clindamycin—CYP3A4—Doxorubicin—testicular cancer	0.0357	0.14	CbGbCtD
Clindamycin—Flushing—Etoposide—testicular cancer	0.00137	0.00184	CcSEcCtD
Clindamycin—Discomfort—Ifosfamide—testicular cancer	0.00137	0.00184	CcSEcCtD
Clindamycin—Hypersensitivity—Vinblastine—testicular cancer	0.00136	0.00183	CcSEcCtD
Clindamycin—Dermatitis exfoliative—Methotrexate—testicular cancer	0.00136	0.00182	CcSEcCtD
Clindamycin—Muscle spasms—Cisplatin—testicular cancer	0.00135	0.00182	CcSEcCtD
Clindamycin—Pain—Bleomycin—testicular cancer	0.00133	0.00179	CcSEcCtD
Clindamycin—Anaphylactic shock—Ifosfamide—testicular cancer	0.00133	0.00179	CcSEcCtD
Clindamycin—Anaphylactoid reaction—Methotrexate—testicular cancer	0.00132	0.00178	CcSEcCtD
Clindamycin—Asthenia—Vinblastine—testicular cancer	0.00132	0.00178	CcSEcCtD
Clindamycin—Thrombocytopenia—Ifosfamide—testicular cancer	0.0013	0.00175	CcSEcCtD
Clindamycin—Anaemia—Cisplatin—testicular cancer	0.0013	0.00175	CcSEcCtD
Clindamycin—Thrombophlebitis—Doxorubicin—testicular cancer	0.00128	0.00172	CcSEcCtD
Clindamycin—Vomiting—Chlorambucil—testicular cancer	0.00128	0.00172	CcSEcCtD
Clindamycin—Dermatitis exfoliative—Epirubicin—testicular cancer	0.00127	0.00171	CcSEcCtD
Clindamycin—Diarrhoea—Vinblastine—testicular cancer	0.00126	0.00169	CcSEcCtD
Clindamycin—Dysgeusia—Etoposide—testicular cancer	0.00126	0.00169	CcSEcCtD
Clindamycin—Leukopenia—Cisplatin—testicular cancer	0.00126	0.00169	CcSEcCtD
Clindamycin—Dermatitis bullous—Epirubicin—testicular cancer	0.00125	0.00169	CcSEcCtD
Clindamycin—Fatigue—Dactinomycin—testicular cancer	0.00125	0.00168	CcSEcCtD
Clindamycin—Back pain—Etoposide—testicular cancer	0.00125	0.00167	CcSEcCtD
Clindamycin—Hypotension—Ifosfamide—testicular cancer	0.00124	0.00167	CcSEcCtD
Clindamycin—Pain—Dactinomycin—testicular cancer	0.00124	0.00167	CcSEcCtD
Clindamycin—Anaphylactoid reaction—Epirubicin—testicular cancer	0.00124	0.00166	CcSEcCtD
Clindamycin—Muscle spasms—Etoposide—testicular cancer	0.00124	0.00166	CcSEcCtD
Clindamycin—Urticaria—Bleomycin—testicular cancer	0.00124	0.00166	CcSEcCtD
Clindamycin—Body temperature increased—Bleomycin—testicular cancer	0.00123	0.00165	CcSEcCtD
Clindamycin—Dizziness—Vinblastine—testicular cancer	0.00122	0.00164	CcSEcCtD
Clindamycin—Nausea—Chlorambucil—testicular cancer	0.0012	0.00161	CcSEcCtD
Clindamycin—Anaemia—Etoposide—testicular cancer	0.00119	0.0016	CcSEcCtD
Clindamycin—Gastrointestinal pain—Dactinomycin—testicular cancer	0.00119	0.0016	CcSEcCtD
Clindamycin—Dyspnoea—Ifosfamide—testicular cancer	0.00119	0.00159	CcSEcCtD
Clindamycin—Discomfort—Cisplatin—testicular cancer	0.00118	0.00159	CcSEcCtD
Clindamycin—Dermatitis exfoliative—Doxorubicin—testicular cancer	0.00118	0.00158	CcSEcCtD
Clindamycin—Vomiting—Vinblastine—testicular cancer	0.00117	0.00158	CcSEcCtD
Clindamycin—Dermatitis bullous—Doxorubicin—testicular cancer	0.00116	0.00156	CcSEcCtD
Clindamycin—Vertigo—Etoposide—testicular cancer	0.00116	0.00155	CcSEcCtD
Clindamycin—Headache—Vinblastine—testicular cancer	0.00116	0.00155	CcSEcCtD
Clindamycin—Toxic epidermal necrolysis—Methotrexate—testicular cancer	0.00115	0.00155	CcSEcCtD
Clindamycin—Leukopenia—Etoposide—testicular cancer	0.00115	0.00155	CcSEcCtD
Clindamycin—Gastrointestinal disorder—Ifosfamide—testicular cancer	0.00115	0.00154	CcSEcCtD
Clindamycin—Body temperature increased—Dactinomycin—testicular cancer	0.00115	0.00154	CcSEcCtD
Clindamycin—Abdominal pain—Dactinomycin—testicular cancer	0.00115	0.00154	CcSEcCtD
Clindamycin—Fatigue—Ifosfamide—testicular cancer	0.00115	0.00154	CcSEcCtD
Clindamycin—Anaphylactic shock—Cisplatin—testicular cancer	0.00115	0.00154	CcSEcCtD
Clindamycin—Hypersensitivity—Bleomycin—testicular cancer	0.00115	0.00154	CcSEcCtD
Clindamycin—Anaphylactoid reaction—Doxorubicin—testicular cancer	0.00115	0.00154	CcSEcCtD
Clindamycin—Cardiac arrest—Epirubicin—testicular cancer	0.00114	0.00153	CcSEcCtD
Clindamycin—Pain—Ifosfamide—testicular cancer	0.00114	0.00153	CcSEcCtD
Clindamycin—Constipation—Ifosfamide—testicular cancer	0.00114	0.00153	CcSEcCtD
Clindamycin—Thrombocytopenia—Cisplatin—testicular cancer	0.00112	0.00151	CcSEcCtD
Clindamycin—Asthenia—Bleomycin—testicular cancer	0.00112	0.0015	CcSEcCtD
Clindamycin—Hypertension—Etoposide—testicular cancer	0.00111	0.00149	CcSEcCtD
Clindamycin—Pruritus—Bleomycin—testicular cancer	0.0011	0.00148	CcSEcCtD
Clindamycin—Dry skin—Epirubicin—testicular cancer	0.0011	0.00148	CcSEcCtD
Clindamycin—Eosinophilia—Methotrexate—testicular cancer	0.0011	0.00147	CcSEcCtD
Clindamycin—Nausea—Vinblastine—testicular cancer	0.0011	0.00147	CcSEcCtD
Clindamycin—Abdominal pain upper—Epirubicin—testicular cancer	0.0011	0.00147	CcSEcCtD
Clindamycin—Gastrointestinal pain—Ifosfamide—testicular cancer	0.00109	0.00146	CcSEcCtD
Clindamycin—Discomfort—Etoposide—testicular cancer	0.00108	0.00146	CcSEcCtD
Clindamycin—Toxic epidermal necrolysis—Epirubicin—testicular cancer	0.00108	0.00145	CcSEcCtD
Clindamycin—Hypotension—Cisplatin—testicular cancer	0.00107	0.00144	CcSEcCtD
Clindamycin—Hypersensitivity—Dactinomycin—testicular cancer	0.00107	0.00144	CcSEcCtD
Clindamycin—Abdominal discomfort—Methotrexate—testicular cancer	0.00106	0.00143	CcSEcCtD
Clindamycin—Urticaria—Ifosfamide—testicular cancer	0.00106	0.00142	CcSEcCtD
Clindamycin—Cardiac arrest—Doxorubicin—testicular cancer	0.00106	0.00142	CcSEcCtD
Clindamycin—Body temperature increased—Ifosfamide—testicular cancer	0.00105	0.00141	CcSEcCtD
Clindamycin—Abdominal pain—Ifosfamide—testicular cancer	0.00105	0.00141	CcSEcCtD
Clindamycin—Anaphylactic shock—Etoposide—testicular cancer	0.00105	0.00141	CcSEcCtD
Clindamycin—Abdominal distension—Epirubicin—testicular cancer	0.00104	0.0014	CcSEcCtD
Clindamycin—Asthenia—Dactinomycin—testicular cancer	0.00104	0.0014	CcSEcCtD
Clindamycin—Dysuria—Methotrexate—testicular cancer	0.00104	0.00139	CcSEcCtD
Clindamycin—Neutropenia—Methotrexate—testicular cancer	0.00104	0.00139	CcSEcCtD
Clindamycin—Thrombocytopenia—Etoposide—testicular cancer	0.00103	0.00138	CcSEcCtD
Clindamycin—Upper respiratory tract infection—Methotrexate—testicular cancer	0.00103	0.00138	CcSEcCtD
Clindamycin—Eosinophilia—Epirubicin—testicular cancer	0.00103	0.00138	CcSEcCtD
Clindamycin—Dyspnoea—Cisplatin—testicular cancer	0.00102	0.00137	CcSEcCtD
Clindamycin—Dry skin—Doxorubicin—testicular cancer	0.00102	0.00137	CcSEcCtD
Clindamycin—Abdominal pain upper—Doxorubicin—testicular cancer	0.00101	0.00136	CcSEcCtD
Clindamycin—Photosensitivity reaction—Methotrexate—testicular cancer	0.00101	0.00136	CcSEcCtD
Clindamycin—Toxic epidermal necrolysis—Doxorubicin—testicular cancer	0.000999	0.00134	CcSEcCtD
Clindamycin—Diarrhoea—Dactinomycin—testicular cancer	0.000994	0.00134	CcSEcCtD
Clindamycin—Gastrointestinal disorder—Cisplatin—testicular cancer	0.000991	0.00133	CcSEcCtD
Clindamycin—Vomiting—Bleomycin—testicular cancer	0.000991	0.00133	CcSEcCtD
Clindamycin—Hypotension—Etoposide—testicular cancer	0.000983	0.00132	CcSEcCtD
Clindamycin—Rash—Bleomycin—testicular cancer	0.000982	0.00132	CcSEcCtD
Clindamycin—Pain—Cisplatin—testicular cancer	0.000982	0.00132	CcSEcCtD
Clindamycin—Dermatitis—Bleomycin—testicular cancer	0.000981	0.00132	CcSEcCtD
Clindamycin—Hypersensitivity—Ifosfamide—testicular cancer	0.000981	0.00132	CcSEcCtD
Clindamycin—Stevens-Johnson syndrome—Methotrexate—testicular cancer	0.000979	0.00131	CcSEcCtD
Clindamycin—Neutropenia—Epirubicin—testicular cancer	0.000969	0.0013	CcSEcCtD
Clindamycin—Dysuria—Epirubicin—testicular cancer	0.000969	0.0013	CcSEcCtD
Clindamycin—Abdominal distension—Doxorubicin—testicular cancer	0.000966	0.0013	CcSEcCtD
Clindamycin—Upper respiratory tract infection—Epirubicin—testicular cancer	0.000963	0.00129	CcSEcCtD
Clindamycin—Asthenia—Ifosfamide—testicular cancer	0.000955	0.00128	CcSEcCtD
Clindamycin—Eosinophilia—Doxorubicin—testicular cancer	0.00095	0.00128	CcSEcCtD
Clindamycin—Photosensitivity reaction—Epirubicin—testicular cancer	0.000946	0.00127	CcSEcCtD
Clindamycin—Pruritus—Ifosfamide—testicular cancer	0.000942	0.00127	CcSEcCtD
Clindamycin—Dyspnoea—Etoposide—testicular cancer	0.000938	0.00126	CcSEcCtD
Clindamycin—Epistaxis—Methotrexate—testicular cancer	0.000932	0.00125	CcSEcCtD
Clindamycin—Nausea—Bleomycin—testicular cancer	0.000925	0.00124	CcSEcCtD
Clindamycin—Vomiting—Dactinomycin—testicular cancer	0.000924	0.00124	CcSEcCtD
Clindamycin—Agranulocytosis—Methotrexate—testicular cancer	0.000922	0.00124	CcSEcCtD
Clindamycin—Stevens-Johnson syndrome—Epirubicin—testicular cancer	0.000916	0.00123	CcSEcCtD
Clindamycin—Rash—Dactinomycin—testicular cancer	0.000916	0.00123	CcSEcCtD
Clindamycin—Diarrhoea—Ifosfamide—testicular cancer	0.000911	0.00122	CcSEcCtD
Clindamycin—Gastrointestinal disorder—Etoposide—testicular cancer	0.000908	0.00122	CcSEcCtD
Clindamycin—Body temperature increased—Cisplatin—testicular cancer	0.000907	0.00122	CcSEcCtD
Clindamycin—Fatigue—Etoposide—testicular cancer	0.000907	0.00122	CcSEcCtD
Clindamycin—Jaundice—Epirubicin—testicular cancer	0.000901	0.00121	CcSEcCtD
Clindamycin—Pain—Etoposide—testicular cancer	0.000899	0.00121	CcSEcCtD
Clindamycin—Constipation—Etoposide—testicular cancer	0.000899	0.00121	CcSEcCtD
Clindamycin—Urinary tract infection—Epirubicin—testicular cancer	0.000898	0.00121	CcSEcCtD
Clindamycin—Dysuria—Doxorubicin—testicular cancer	0.000897	0.0012	CcSEcCtD
Clindamycin—Neutropenia—Doxorubicin—testicular cancer	0.000897	0.0012	CcSEcCtD
Clindamycin—Upper respiratory tract infection—Doxorubicin—testicular cancer	0.000891	0.0012	CcSEcCtD
Clindamycin—Dizziness—Ifosfamide—testicular cancer	0.00088	0.00118	CcSEcCtD
Clindamycin—Photosensitivity reaction—Doxorubicin—testicular cancer	0.000875	0.00118	CcSEcCtD
Clindamycin—Epistaxis—Epirubicin—testicular cancer	0.000872	0.00117	CcSEcCtD
Clindamycin—Nausea—Dactinomycin—testicular cancer	0.000863	0.00116	CcSEcCtD
Clindamycin—Agranulocytosis—Epirubicin—testicular cancer	0.000863	0.00116	CcSEcCtD
Clindamycin—Gastrointestinal pain—Etoposide—testicular cancer	0.00086	0.00115	CcSEcCtD
Clindamycin—Stevens-Johnson syndrome—Doxorubicin—testicular cancer	0.000848	0.00114	CcSEcCtD
Clindamycin—Vomiting—Ifosfamide—testicular cancer	0.000847	0.00114	CcSEcCtD
Clindamycin—Hypersensitivity—Cisplatin—testicular cancer	0.000846	0.00114	CcSEcCtD
Clindamycin—Rash—Ifosfamide—testicular cancer	0.00084	0.00113	CcSEcCtD
Clindamycin—Dermatitis—Ifosfamide—testicular cancer	0.000839	0.00113	CcSEcCtD
Clindamycin—Erythema multiforme—Methotrexate—testicular cancer	0.000838	0.00113	CcSEcCtD
Clindamycin—Urticaria—Etoposide—testicular cancer	0.000835	0.00112	CcSEcCtD
Clindamycin—Jaundice—Doxorubicin—testicular cancer	0.000834	0.00112	CcSEcCtD
Clindamycin—Body temperature increased—Etoposide—testicular cancer	0.000831	0.00112	CcSEcCtD
Clindamycin—Abdominal pain—Etoposide—testicular cancer	0.000831	0.00112	CcSEcCtD
Clindamycin—Urinary tract infection—Doxorubicin—testicular cancer	0.000831	0.00112	CcSEcCtD
Clindamycin—Asthenia—Cisplatin—testicular cancer	0.000824	0.00111	CcSEcCtD
Clindamycin—Epistaxis—Doxorubicin—testicular cancer	0.000807	0.00108	CcSEcCtD
Clindamycin—Agranulocytosis—Doxorubicin—testicular cancer	0.000798	0.00107	CcSEcCtD
Clindamycin—Nausea—Ifosfamide—testicular cancer	0.000791	0.00106	CcSEcCtD
Clindamycin—Diarrhoea—Cisplatin—testicular cancer	0.000785	0.00105	CcSEcCtD
Clindamycin—Erythema multiforme—Epirubicin—testicular cancer	0.000785	0.00105	CcSEcCtD
Clindamycin—Hypersensitivity—Etoposide—testicular cancer	0.000775	0.00104	CcSEcCtD
Clindamycin—Erythema—Methotrexate—testicular cancer	0.000772	0.00104	CcSEcCtD
Clindamycin—Flushing—Epirubicin—testicular cancer	0.00077	0.00103	CcSEcCtD
Clindamycin—Dysgeusia—Methotrexate—testicular cancer	0.000756	0.00102	CcSEcCtD
Clindamycin—Asthenia—Etoposide—testicular cancer	0.000755	0.00101	CcSEcCtD
Clindamycin—Back pain—Methotrexate—testicular cancer	0.000747	0.001	CcSEcCtD
Clindamycin—Pruritus—Etoposide—testicular cancer	0.000744	0.000999	CcSEcCtD
Clindamycin—Vomiting—Cisplatin—testicular cancer	0.00073	0.00098	CcSEcCtD
Clindamycin—Erythema multiforme—Doxorubicin—testicular cancer	0.000726	0.000975	CcSEcCtD
Clindamycin—Rash—Cisplatin—testicular cancer	0.000724	0.000972	CcSEcCtD
Clindamycin—Dermatitis—Cisplatin—testicular cancer	0.000723	0.000971	CcSEcCtD
Clindamycin—Erythema—Epirubicin—testicular cancer	0.000722	0.00097	CcSEcCtD
Clindamycin—Diarrhoea—Etoposide—testicular cancer	0.00072	0.000966	CcSEcCtD
Clindamycin—Anaemia—Methotrexate—testicular cancer	0.000713	0.000958	CcSEcCtD
Clindamycin—Flushing—Doxorubicin—testicular cancer	0.000713	0.000957	CcSEcCtD
Clindamycin—Flatulence—Epirubicin—testicular cancer	0.000712	0.000956	CcSEcCtD
Clindamycin—Dysgeusia—Epirubicin—testicular cancer	0.000707	0.00095	CcSEcCtD
Clindamycin—Back pain—Epirubicin—testicular cancer	0.000699	0.000938	CcSEcCtD
Clindamycin—Dizziness—Etoposide—testicular cancer	0.000695	0.000934	CcSEcCtD
Clindamycin—Muscle spasms—Epirubicin—testicular cancer	0.000694	0.000933	CcSEcCtD
Clindamycin—Vertigo—Methotrexate—testicular cancer	0.000693	0.000931	CcSEcCtD
Clindamycin—Leukopenia—Methotrexate—testicular cancer	0.000691	0.000928	CcSEcCtD
Clindamycin—Nausea—Cisplatin—testicular cancer	0.000682	0.000916	CcSEcCtD
Clindamycin—Vomiting—Etoposide—testicular cancer	0.000669	0.000898	CcSEcCtD
Clindamycin—Erythema—Doxorubicin—testicular cancer	0.000668	0.000898	CcSEcCtD
Clindamycin—Anaemia—Epirubicin—testicular cancer	0.000668	0.000897	CcSEcCtD
Clindamycin—Rash—Etoposide—testicular cancer	0.000663	0.00089	CcSEcCtD
Clindamycin—Dermatitis—Etoposide—testicular cancer	0.000662	0.00089	CcSEcCtD
Clindamycin—Headache—Etoposide—testicular cancer	0.000659	0.000885	CcSEcCtD
Clindamycin—Flatulence—Doxorubicin—testicular cancer	0.000659	0.000884	CcSEcCtD
Clindamycin—Dysgeusia—Doxorubicin—testicular cancer	0.000654	0.000879	CcSEcCtD
Clindamycin—Discomfort—Methotrexate—testicular cancer	0.000649	0.000872	CcSEcCtD
Clindamycin—Vertigo—Epirubicin—testicular cancer	0.000649	0.000871	CcSEcCtD
Clindamycin—Leukopenia—Epirubicin—testicular cancer	0.000647	0.000868	CcSEcCtD
Clindamycin—Back pain—Doxorubicin—testicular cancer	0.000646	0.000868	CcSEcCtD
Clindamycin—Muscle spasms—Doxorubicin—testicular cancer	0.000643	0.000863	CcSEcCtD
Clindamycin—Anaphylactic shock—Methotrexate—testicular cancer	0.00063	0.000846	CcSEcCtD
Clindamycin—Nausea—Etoposide—testicular cancer	0.000625	0.000839	CcSEcCtD
Clindamycin—Hypertension—Epirubicin—testicular cancer	0.000624	0.000837	CcSEcCtD
Clindamycin—Anaemia—Doxorubicin—testicular cancer	0.000618	0.00083	CcSEcCtD
Clindamycin—Thrombocytopenia—Methotrexate—testicular cancer	0.000617	0.000828	CcSEcCtD
Clindamycin—Discomfort—Epirubicin—testicular cancer	0.000608	0.000816	CcSEcCtD
Clindamycin—Vertigo—Doxorubicin—testicular cancer	0.0006	0.000806	CcSEcCtD
Clindamycin—Leukopenia—Doxorubicin—testicular cancer	0.000598	0.000803	CcSEcCtD
Clindamycin—Anaphylactic shock—Epirubicin—testicular cancer	0.000589	0.000792	CcSEcCtD
Clindamycin—Hypotension—Methotrexate—testicular cancer	0.000589	0.00079	CcSEcCtD
Clindamycin—Thrombocytopenia—Epirubicin—testicular cancer	0.000577	0.000775	CcSEcCtD
Clindamycin—Hypertension—Doxorubicin—testicular cancer	0.000577	0.000775	CcSEcCtD
Clindamycin—Discomfort—Doxorubicin—testicular cancer	0.000562	0.000755	CcSEcCtD
Clindamycin—Dyspnoea—Methotrexate—testicular cancer	0.000562	0.000754	CcSEcCtD
Clindamycin—Dyspepsia—Methotrexate—testicular cancer	0.000554	0.000745	CcSEcCtD
Clindamycin—Hypotension—Epirubicin—testicular cancer	0.000551	0.00074	CcSEcCtD
Clindamycin—Anaphylactic shock—Doxorubicin—testicular cancer	0.000545	0.000733	CcSEcCtD
Clindamycin—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000544	0.00073	CcSEcCtD
Clindamycin—Fatigue—Methotrexate—testicular cancer	0.000543	0.000729	CcSEcCtD
Clindamycin—Pain—Methotrexate—testicular cancer	0.000539	0.000723	CcSEcCtD
Clindamycin—Thrombocytopenia—Doxorubicin—testicular cancer	0.000534	0.000717	CcSEcCtD
Clindamycin—Dyspnoea—Epirubicin—testicular cancer	0.000526	0.000706	CcSEcCtD
Clindamycin—Dyspepsia—Epirubicin—testicular cancer	0.000519	0.000697	CcSEcCtD
Clindamycin—Gastrointestinal pain—Methotrexate—testicular cancer	0.000515	0.000692	CcSEcCtD
Clindamycin—Hypotension—Doxorubicin—testicular cancer	0.00051	0.000684	CcSEcCtD
Clindamycin—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000509	0.000683	CcSEcCtD
Clindamycin—Fatigue—Epirubicin—testicular cancer	0.000508	0.000683	CcSEcCtD
Clindamycin—Pain—Epirubicin—testicular cancer	0.000504	0.000677	CcSEcCtD
Clindamycin—Constipation—Epirubicin—testicular cancer	0.000504	0.000677	CcSEcCtD
Clindamycin—Urticaria—Methotrexate—testicular cancer	0.0005	0.000672	CcSEcCtD
Clindamycin—Body temperature increased—Methotrexate—testicular cancer	0.000498	0.000669	CcSEcCtD
Clindamycin—Abdominal pain—Methotrexate—testicular cancer	0.000498	0.000669	CcSEcCtD
Clindamycin—Dyspnoea—Doxorubicin—testicular cancer	0.000486	0.000653	CcSEcCtD
Clindamycin—Gastrointestinal pain—Epirubicin—testicular cancer	0.000482	0.000647	CcSEcCtD
Clindamycin—Dyspepsia—Doxorubicin—testicular cancer	0.00048	0.000645	CcSEcCtD
Clindamycin—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000471	0.000632	CcSEcCtD
Clindamycin—Fatigue—Doxorubicin—testicular cancer	0.00047	0.000632	CcSEcCtD
Clindamycin—Urticaria—Epirubicin—testicular cancer	0.000468	0.000629	CcSEcCtD
Clindamycin—Constipation—Doxorubicin—testicular cancer	0.000466	0.000626	CcSEcCtD
Clindamycin—Pain—Doxorubicin—testicular cancer	0.000466	0.000626	CcSEcCtD
Clindamycin—Abdominal pain—Epirubicin—testicular cancer	0.000466	0.000626	CcSEcCtD
Clindamycin—Body temperature increased—Epirubicin—testicular cancer	0.000466	0.000626	CcSEcCtD
Clindamycin—Hypersensitivity—Methotrexate—testicular cancer	0.000464	0.000623	CcSEcCtD
Clindamycin—Asthenia—Methotrexate—testicular cancer	0.000452	0.000607	CcSEcCtD
Clindamycin—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000446	0.000599	CcSEcCtD
Clindamycin—Pruritus—Methotrexate—testicular cancer	0.000446	0.000598	CcSEcCtD
Clindamycin—Hypersensitivity—Epirubicin—testicular cancer	0.000434	0.000583	CcSEcCtD
Clindamycin—Urticaria—Doxorubicin—testicular cancer	0.000433	0.000582	CcSEcCtD
Clindamycin—Abdominal pain—Doxorubicin—testicular cancer	0.000431	0.000579	CcSEcCtD
Clindamycin—Body temperature increased—Doxorubicin—testicular cancer	0.000431	0.000579	CcSEcCtD
Clindamycin—Diarrhoea—Methotrexate—testicular cancer	0.000431	0.000579	CcSEcCtD
Clindamycin—Asthenia—Epirubicin—testicular cancer	0.000423	0.000568	CcSEcCtD
Clindamycin—Pruritus—Epirubicin—testicular cancer	0.000417	0.00056	CcSEcCtD
Clindamycin—Dizziness—Methotrexate—testicular cancer	0.000417	0.000559	CcSEcCtD
Clindamycin—Diarrhoea—Epirubicin—testicular cancer	0.000403	0.000542	CcSEcCtD
Clindamycin—Hypersensitivity—Doxorubicin—testicular cancer	0.000402	0.00054	CcSEcCtD
Clindamycin—Vomiting—Methotrexate—testicular cancer	0.0004	0.000538	CcSEcCtD
Clindamycin—Rash—Methotrexate—testicular cancer	0.000397	0.000533	CcSEcCtD
Clindamycin—Dermatitis—Methotrexate—testicular cancer	0.000397	0.000533	CcSEcCtD
Clindamycin—Headache—Methotrexate—testicular cancer	0.000395	0.00053	CcSEcCtD
Clindamycin—Asthenia—Doxorubicin—testicular cancer	0.000391	0.000526	CcSEcCtD
Clindamycin—Dizziness—Epirubicin—testicular cancer	0.00039	0.000524	CcSEcCtD
Clindamycin—Pruritus—Doxorubicin—testicular cancer	0.000386	0.000518	CcSEcCtD
Clindamycin—Vomiting—Epirubicin—testicular cancer	0.000375	0.000503	CcSEcCtD
Clindamycin—Nausea—Methotrexate—testicular cancer	0.000374	0.000502	CcSEcCtD
Clindamycin—Diarrhoea—Doxorubicin—testicular cancer	0.000373	0.000501	CcSEcCtD
Clindamycin—Rash—Epirubicin—testicular cancer	0.000372	0.000499	CcSEcCtD
Clindamycin—Dermatitis—Epirubicin—testicular cancer	0.000371	0.000499	CcSEcCtD
Clindamycin—Headache—Epirubicin—testicular cancer	0.000369	0.000496	CcSEcCtD
Clindamycin—Dizziness—Doxorubicin—testicular cancer	0.000361	0.000484	CcSEcCtD
Clindamycin—Nausea—Epirubicin—testicular cancer	0.00035	0.00047	CcSEcCtD
Clindamycin—Vomiting—Doxorubicin—testicular cancer	0.000347	0.000466	CcSEcCtD
Clindamycin—Rash—Doxorubicin—testicular cancer	0.000344	0.000462	CcSEcCtD
Clindamycin—Dermatitis—Doxorubicin—testicular cancer	0.000344	0.000461	CcSEcCtD
Clindamycin—Headache—Doxorubicin—testicular cancer	0.000342	0.000459	CcSEcCtD
Clindamycin—Nausea—Doxorubicin—testicular cancer	0.000324	0.000435	CcSEcCtD
